Philips announces FDA submission for BlueSeal Horizon, the industry’s first helium-free 3.0T MRI
The regulatory milestone marks a key step in bringing helium-free technology to 3.0T MRI
- Nov 17, 2026
- 2 minute read
At RSNA 2026 in Chicago, Philips plans to highlight BlueSeal Horizon and its latest imaging innovations. Across the portfolio, Philips brings imaging systems, software, data, AI and services together through open platforms that connect people, information and care settings.
Philips today announced that its BlueSeal Horizon SI, XI and ZI 3.0T MRI systems [1] have been submitted to the US Food and Drug Administration (FDA) for 510(k) clearance. The industry’s first 3.0T high-performance helium-free MRI platform, BlueSeal Horizon expands Philips’ BlueSeal portfolio of helium-free [2] MR to 3.0T and offers a range of new features alongside next-generation advanced clinical AI solutions designed to support multiple specialties, simplify workflows and support clinical decision-making.
Philips has led in the development of helium-free MRI since 2018 with the introduction of its BlueSeal 1.5T systems. Today, more than 2,500 BlueSeal 1.5T systems are installed worldwide, saving more than 7 million liters of liquid helium to date [3], eliminating the need for helium refills and vent pipes, and helping reduce siting complexity, installation time and lifecycle risk.
The FDA submission of BlueSeal Horizon marks an important step toward bringing the benefits of helium-free 3.0T MRI to more healthcare providers and patients.
Ioannis Panagiotelis, PhD
“The FDA submission of BlueSeal Horizon marks an important step toward bringing the benefits of helium-free 3.0T MRI to more healthcare providers and patients,” said Ioannis Panagiotelis, PhD, Business Leader, MR at Philips. “As healthcare teams respond to growing demand for MRI, both innovation and resilience are critical to delivering the best care possible. BlueSeal Horizon brings these priorities together, and I am immensely proud of the team as we have paved the way toward advancing helium-free technology to 3.0T to support both radiology teams and the patients they serve.”
See Philips MR portfolio at RSNA 2026
Philips innovations help simplify workflows and support confident diagnostic decisions, giving care teams more time to apply their expertise where it matters most and helping more patients get confident diagnosis and treatment faster. Attendees can learn more at the Philips RSNA booth #6730 and here.
Sources
- BlueSeal Horizon 3.0T MRI is pending FDA 510(k) clearance in the United States. It is not available for sale in any jurisdiction.
- Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.
- The amount of liquid helium saved is a calculation compared to a previous generation magnet with 1500 liters of helium.